POLICY LETTER
The Society for Women’s Health Research recently sent a letter to the Biden Administration, expressing support for expanding access to anti-obesity medications (AOMs) under Medicare Part D.
“This proposed rule demonstrates a significant step toward ensuring that all individuals have access to the care they need to lead healthy lives,” the letter states.